Apricus Biosciences (APRI) Misses Q3 EPS by 13c

Apricus Biosciences (NASDAQ: APRI) reported Q3 EPS of ($0.29), $0.13 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Apricus Biosciences (APRI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance